ReP USP - Resultado da busca

Artigo de periodico
The course of attention-deficit/hyperactivity disorder through midlife (2024)
Grevet, Eugenio Horacio ; Bandeira, Cibele Edom ; Vitola, Eduardo Schneider ; Tavares, Maria Eduarda de Araujo ; Breda, Vitor ; Zeni, Gregory David ; Teche, Stefania Pigatto ; Picon, Felipe Almeida ; Salgado, Carlos Alberto Iglesias ; Karam, Rafael Gomes ; Silva, Bruna Santos da ; Sibley, Margaret H.; Rohde, Luis Augusto ; Cupertino, Renata Basso ; Bau, Claiton Henrique Dotto ; Rovaris, Diego Luiz
Source: European Archives of Psychiatry and Clinical Neuroscience. Unidade: ICB
Subjects: FISIOLOGIA, TRANSTORNO DO DEFICIT DE ATENÇÃO COM HIPERATIVIDADE, COMORBIDADE, ATENÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GREVET, Eugenio Horacio et al. The course of attention-deficit/hyperactivity disorder through midlife. European Archives of Psychiatry and Clinical Neuroscience, v. 274, n. 1, p. 59-70, 2024Tradução . . Disponível em: https://doi.org/10.1007/s00406-022-01531-4. Acesso em: 20 maio 2024.
APA
Grevet, E. H., Bandeira, C. E., Vitola, E. S., Tavares, M. E. de A., Breda, V., Zeni, G. D., et al. (2024). The course of attention-deficit/hyperactivity disorder through midlife. European Archives of Psychiatry and Clinical Neuroscience, 274( 1), 59-70. doi:10.1007/s00406-022-01531-4
NLM
Grevet EH, Bandeira CE, Vitola ES, Tavares ME de A, Breda V, Zeni GD, Teche SP, Picon FA, Salgado CAI, Karam RG, Silva BS da, Sibley MH, Rohde LA, Cupertino RB, Bau CHD, Rovaris DL. The course of attention-deficit/hyperactivity disorder through midlife [Internet]. European Archives of Psychiatry and Clinical Neuroscience. 2024 ; 274( 1): 59-70.[citado 2024 maio 20 ] Available from: https://doi.org/10.1007/s00406-022-01531-4
Vancouver
Grevet EH, Bandeira CE, Vitola ES, Tavares ME de A, Breda V, Zeni GD, Teche SP, Picon FA, Salgado CAI, Karam RG, Silva BS da, Sibley MH, Rohde LA, Cupertino RB, Bau CHD, Rovaris DL. The course of attention-deficit/hyperactivity disorder through midlife [Internet]. European Archives of Psychiatry and Clinical Neuroscience. 2024 ; 274( 1): 59-70.[citado 2024 maio 20 ] Available from: https://doi.org/10.1007/s00406-022-01531-4
Artigo de periodico
The effects of ketamine and classic hallucinogens on neurotrophic and inflammatory markers in unipolar treatment-resistant depression: a systematic review of clinical trials (2023)
Rossi, Giordano Novak; Hallak, Jaime Eduardo Cecilio ; Baker, Glen; Dursun, Serdar M.; Santos, Rafael Guimarães dos
Source: European Archives of Psychiatry and Clinical Neuroscience. Unidade: FMRP
Subjects: BIOMARCADORES, ANESTÉSICOS, ALUCINOGÊNICOS, DEPRESSÃO, ENSAIO CLÍNICO CONTROLADO RANDOMIZADO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROSSI, Giordano Novak et al. The effects of ketamine and classic hallucinogens on neurotrophic and inflammatory markers in unipolar treatment-resistant depression: a systematic review of clinical trials. European Archives of Psychiatry and Clinical Neuroscience, 2023Tradução . . Disponível em: https://doi.org/10.1007/s00406-022-01460-2. Acesso em: 20 maio 2024.
APA
Rossi, G. N., Hallak, J. E. C., Baker, G., Dursun, S. M., & Santos, R. G. dos. (2023). The effects of ketamine and classic hallucinogens on neurotrophic and inflammatory markers in unipolar treatment-resistant depression: a systematic review of clinical trials. European Archives of Psychiatry and Clinical Neuroscience. doi:10.1007/s00406-022-01460-2
NLM
Rossi GN, Hallak JEC, Baker G, Dursun SM, Santos RG dos. The effects of ketamine and classic hallucinogens on neurotrophic and inflammatory markers in unipolar treatment-resistant depression: a systematic review of clinical trials [Internet]. European Archives of Psychiatry and Clinical Neuroscience. 2023 ;[citado 2024 maio 20 ] Available from: https://doi.org/10.1007/s00406-022-01460-2
Vancouver
Rossi GN, Hallak JEC, Baker G, Dursun SM, Santos RG dos. The effects of ketamine and classic hallucinogens on neurotrophic and inflammatory markers in unipolar treatment-resistant depression: a systematic review of clinical trials [Internet]. European Archives of Psychiatry and Clinical Neuroscience. 2023 ;[citado 2024 maio 20 ] Available from: https://doi.org/10.1007/s00406-022-01460-2
Artigo de periodico
Dissecting the cross-trait effects of the FOXP2 GWAS hit on clinical and brain phenotypes in adults with ADHD (2023)
Meyer, Gabriela Pessin; Silva, Bruna Santos da ; Bandeira, Cibele Edom ; Tavares, Maria Eduarda Araujo ; Cupertino, Renata Basso ; Oliveira, Eduarda Pereira; Diana Müller ; Kappel, Djenifer B. ; Stefania Pigatto Teche ; Vitola, Eduardo Schneider ; Luis Augusto Rhode ; Bau, Claiton Henrique Dotto ; Rovaris, Diego Luiz
Source: European Archives of Psychiatry and Clinical Neuroscience. Unidade: ICB
Subjects: FISIOLOGIA, ATENÇÃO, TRANSTORNO DO DEFICIT DE ATENÇÃO COM HIPERATIVIDADE, HIPERATIVIDADE, TRANSTORNO AUTÍSTICO, TRAÇOS DE PERSONALIDADE, PSIQUIATRIA, CÉREBRO, FENÓTIPOS, FATORES DE TRANSCRIÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MEYER, Gabriela Pessin et al. Dissecting the cross-trait effects of the FOXP2 GWAS hit on clinical and brain phenotypes in adults with ADHD. European Archives of Psychiatry and Clinical Neuroscience, v. 273, p. 15–24, 2023Tradução . . Disponível em: https://doi.org/10.1007/s00406-022-01388-7. Acesso em: 20 maio 2024.
APA
Meyer, G. P., Silva, B. S. da, Bandeira, C. E., Tavares, M. E. A., Cupertino, R. B., Oliveira, E. P., et al. (2023). Dissecting the cross-trait effects of the FOXP2 GWAS hit on clinical and brain phenotypes in adults with ADHD. European Archives of Psychiatry and Clinical Neuroscience, 273, 15–24. doi:10.1007/s00406-022-01388-7
NLM
Meyer GP, Silva BS da, Bandeira CE, Tavares MEA, Cupertino RB, Oliveira EP, Diana Müller, Kappel DB, Stefania Pigatto Teche, Vitola ES, Luis Augusto Rhode, Bau CHD, Rovaris DL. Dissecting the cross-trait effects of the FOXP2 GWAS hit on clinical and brain phenotypes in adults with ADHD [Internet]. European Archives of Psychiatry and Clinical Neuroscience. 2023 ; 273 15–24.[citado 2024 maio 20 ] Available from: https://doi.org/10.1007/s00406-022-01388-7
Vancouver
Meyer GP, Silva BS da, Bandeira CE, Tavares MEA, Cupertino RB, Oliveira EP, Diana Müller, Kappel DB, Stefania Pigatto Teche, Vitola ES, Luis Augusto Rhode, Bau CHD, Rovaris DL. Dissecting the cross-trait effects of the FOXP2 GWAS hit on clinical and brain phenotypes in adults with ADHD [Internet]. European Archives of Psychiatry and Clinical Neuroscience. 2023 ; 273 15–24.[citado 2024 maio 20 ] Available from: https://doi.org/10.1007/s00406-022-01388-7
Artigo de periodico
Cannabinoids modulate proliferation, differentiation, and migration signaling pathways in oligodendrocytes (2022)
Almeida, Valéria de; Seabra, Gabriela; Oliveira, Guilherme Reis de; Zuccoli, Giuliana S.; Rumin, Priscila; Fioramonte, Mariana; Smith, Bradley J.; Zuardi, Antônio Waldo ; Hallak, Jaime Eduardo Cecilio ; Campos, Alline Cristina de ; Crippa, José Alexandre de Souza ; Souza, Daniel Martins de
Source: European Archives of Psychiatry and Clinical Neuroscience. Unidade: FMRP
Subjects: CANABINOIDES, PROLIFERAÇÃO CELULAR, TRANSDUÇÃO DE SINAL CELULAR, PROTEÔMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALMEIDA, Valéria de et al. Cannabinoids modulate proliferation, differentiation, and migration signaling pathways in oligodendrocytes. European Archives of Psychiatry and Clinical Neuroscience, v. 272, n. 7, p. 1311-1323, 2022Tradução . . Disponível em: https://doi.org/10.1007/s00406-022-01425-5. Acesso em: 20 maio 2024.
APA
Almeida, V. de, Seabra, G., Oliveira, G. R. de, Zuccoli, G. S., Rumin, P., Fioramonte, M., et al. (2022). Cannabinoids modulate proliferation, differentiation, and migration signaling pathways in oligodendrocytes. European Archives of Psychiatry and Clinical Neuroscience, 272( 7), 1311-1323. doi:10.1007/s00406-022-01425-5
NLM
Almeida V de, Seabra G, Oliveira GR de, Zuccoli GS, Rumin P, Fioramonte M, Smith BJ, Zuardi AW, Hallak JEC, Campos AC de, Crippa JA de S, Souza DM de. Cannabinoids modulate proliferation, differentiation, and migration signaling pathways in oligodendrocytes [Internet]. European Archives of Psychiatry and Clinical Neuroscience. 2022 ; 272( 7): 1311-1323.[citado 2024 maio 20 ] Available from: https://doi.org/10.1007/s00406-022-01425-5
Vancouver
Almeida V de, Seabra G, Oliveira GR de, Zuccoli GS, Rumin P, Fioramonte M, Smith BJ, Zuardi AW, Hallak JEC, Campos AC de, Crippa JA de S, Souza DM de. Cannabinoids modulate proliferation, differentiation, and migration signaling pathways in oligodendrocytes [Internet]. European Archives of Psychiatry and Clinical Neuroscience. 2022 ; 272( 7): 1311-1323.[citado 2024 maio 20 ] Available from: https://doi.org/10.1007/s00406-022-01425-5
Artigo de periodico
Emerging findings of glutamate–glutamine imbalance in the medial prefrontal cortex in attention deficit/hyperactivity disorder: systematic review and meta-analysis of spectroscopy studies (2022)
Vidor, Marcos Vinícius ; Panzenhagen, Alana Castro ; Martins, Alexandre Ribeiro; Cupertino, Renata Basso ; Bandeira, Cibele Edom ; Picon, Felipe Almeida ; Silva, Bruna Santos da ; Vitola, Eduardo Schneider ; Rhode, Luis Augusto ; Bau, Claiton Henrique Dotto ; Grevet, Eugênio Horácio ; Rovaris, Diego Luiz
Source: European Archives of Psychiatry and Clinical Neuroscience. Unidade: ICB
Subjects: FISIOLOGIA, TRANSTORNO DO DEFICIT DE ATENÇÃO COM HIPERATIVIDADE, GLUTAMATOS, GLUTAMINA, DIAGNÓSTICO POR IMAGEM, RESSONÂNCIA MAGNÉTICA, CÓRTEX PRÉ-FRONTAL, ESPECTROSCOPIA DE RESSONÂNCIA MAGNÉTICA NUCLEAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VIDOR, Marcos Vinícius et al. Emerging findings of glutamate–glutamine imbalance in the medial prefrontal cortex in attention deficit/hyperactivity disorder: systematic review and meta-analysis of spectroscopy studies. European Archives of Psychiatry and Clinical Neuroscience, v. 272, p. 1395–1411, 2022Tradução . . Disponível em: https://doi.org/10.1007/s00406-022-01397-6. Acesso em: 20 maio 2024.
APA
Vidor, M. V., Panzenhagen, A. C., Martins, A. R., Cupertino, R. B., Bandeira, C. E., Picon, F. A., et al. (2022). Emerging findings of glutamate–glutamine imbalance in the medial prefrontal cortex in attention deficit/hyperactivity disorder: systematic review and meta-analysis of spectroscopy studies. European Archives of Psychiatry and Clinical Neuroscience, 272, 1395–1411. doi:10.1007/s00406-022-01397-6
NLM
Vidor MV, Panzenhagen AC, Martins AR, Cupertino RB, Bandeira CE, Picon FA, Silva BS da, Vitola ES, Rhode LA, Bau CHD, Grevet EH, Rovaris DL. Emerging findings of glutamate–glutamine imbalance in the medial prefrontal cortex in attention deficit/hyperactivity disorder: systematic review and meta-analysis of spectroscopy studies [Internet]. European Archives of Psychiatry and Clinical Neuroscience. 2022 ; 272 1395–1411.[citado 2024 maio 20 ] Available from: https://doi.org/10.1007/s00406-022-01397-6
Vancouver
Vidor MV, Panzenhagen AC, Martins AR, Cupertino RB, Bandeira CE, Picon FA, Silva BS da, Vitola ES, Rhode LA, Bau CHD, Grevet EH, Rovaris DL. Emerging findings of glutamate–glutamine imbalance in the medial prefrontal cortex in attention deficit/hyperactivity disorder: systematic review and meta-analysis of spectroscopy studies [Internet]. European Archives of Psychiatry and Clinical Neuroscience. 2022 ; 272 1395–1411.[citado 2024 maio 20 ] Available from: https://doi.org/10.1007/s00406-022-01397-6
Artigo de periodico
Effects of ayahuasca and its alkaloids on substance use disorders: an updated (2016–2020) systematic review of preclinical and human studies (2022)
Rodrigues, Lucas Silva; Rossi, Giordano Novak ; Rocha, Juliana Mendes; Osório, Flávia de Lima ; Bouso, José Carlos; Hallak, Jaime Eduardo Cecilio ; Santos, Rafael Guimarães dos
Source: European Archives of Psychiatry and Clinical Neuroscience. Unidade: FMRP
Subjects: TRANSTORNOS RELACIONADOS AO USO DE SUBSTÂNCIAS, ALUCINOGÊNICOS, DROGAS DE ABUSO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RODRIGUES, Lucas Silva et al. Effects of ayahuasca and its alkaloids on substance use disorders: an updated (2016–2020) systematic review of preclinical and human studies. European Archives of Psychiatry and Clinical Neuroscience, 2022Tradução . . Disponível em: https://doi.org/10.1007/s00406-021-01267-7. Acesso em: 20 maio 2024.
APA
Rodrigues, L. S., Rossi, G. N., Rocha, J. M., Osório, F. de L., Bouso, J. C., Hallak, J. E. C., & Santos, R. G. dos. (2022). Effects of ayahuasca and its alkaloids on substance use disorders: an updated (2016–2020) systematic review of preclinical and human studies. European Archives of Psychiatry and Clinical Neuroscience. doi:10.1007/s00406-021-01267-7
NLM
Rodrigues LS, Rossi GN, Rocha JM, Osório F de L, Bouso JC, Hallak JEC, Santos RG dos. Effects of ayahuasca and its alkaloids on substance use disorders: an updated (2016–2020) systematic review of preclinical and human studies [Internet]. European Archives of Psychiatry and Clinical Neuroscience. 2022 ;[citado 2024 maio 20 ] Available from: https://doi.org/10.1007/s00406-021-01267-7
Vancouver
Rodrigues LS, Rossi GN, Rocha JM, Osório F de L, Bouso JC, Hallak JEC, Santos RG dos. Effects of ayahuasca and its alkaloids on substance use disorders: an updated (2016–2020) systematic review of preclinical and human studies [Internet]. European Archives of Psychiatry and Clinical Neuroscience. 2022 ;[citado 2024 maio 20 ] Available from: https://doi.org/10.1007/s00406-021-01267-7
Artigo de periodico
Linking proteomic alterations in schizophrenia hippocampus to NMDAr hypofunction in human neurons and oligodendrocytes (2021)
Zuccoli, Giuliana da Silva ; Oliveira, Guilherme Reis de; Garbes, Bruna; Falkai, Peter ; Schmitt, Andrea ; Nakaya, Helder Takashi Imoto ; Souza, Daniel Martins de
Source: European Archives of Psychiatry and Clinical Neuroscience. Unidade: FCF
Subjects: NEURÔNIOS, ESQUIZOFRENIA, PROTEÔMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ZUCCOLI, Giuliana da Silva et al. Linking proteomic alterations in schizophrenia hippocampus to NMDAr hypofunction in human neurons and oligodendrocytes. European Archives of Psychiatry and Clinical Neuroscience, v. 271, p. 1579–1586, 2021Tradução . . Disponível em: https://doi.org/10.1007/s00406-021-01248-w. Acesso em: 20 maio 2024.
APA
Zuccoli, G. da S., Oliveira, G. R. de, Garbes, B., Falkai, P., Schmitt, A., Nakaya, H. T. I., & Souza, D. M. de. (2021). Linking proteomic alterations in schizophrenia hippocampus to NMDAr hypofunction in human neurons and oligodendrocytes. European Archives of Psychiatry and Clinical Neuroscience, 271, 1579–1586. doi:10.1007/s00406-021-01248-w
NLM
Zuccoli G da S, Oliveira GR de, Garbes B, Falkai P, Schmitt A, Nakaya HTI, Souza DM de. Linking proteomic alterations in schizophrenia hippocampus to NMDAr hypofunction in human neurons and oligodendrocytes [Internet]. European Archives of Psychiatry and Clinical Neuroscience. 2021 ; 271 1579–1586.[citado 2024 maio 20 ] Available from: https://doi.org/10.1007/s00406-021-01248-w
Vancouver
Zuccoli G da S, Oliveira GR de, Garbes B, Falkai P, Schmitt A, Nakaya HTI, Souza DM de. Linking proteomic alterations in schizophrenia hippocampus to NMDAr hypofunction in human neurons and oligodendrocytes [Internet]. European Archives of Psychiatry and Clinical Neuroscience. 2021 ; 271 1579–1586.[citado 2024 maio 20 ] Available from: https://doi.org/10.1007/s00406-021-01248-w
Artigo de periodico
Cognitive decline following acute viral infections: literature review and projections for post-COVID-19 (2021)
Damiano, Rodolfo Furlan ; Guedes, Bruno Fukelmann ; Rocca, Cristiana Castanho de; Serafim, Antonio de Pádua ; Castro, Luiz Henrique Martins; Munhoz, Carolina Demarchi ; Nitrini, Ricardo ; Busatto Filho, Geraldo ; Miguel Filho, Eurípedes Constantino ; Lucchetti, Giancarlo ; Forlenza, Orestes Vicente
Source: European Archives of Psychiatry and Clinical Neuroscience. Unidades: IP, FM, ICB
Subjects: FARMACOLOGIA, DOENÇA DE ALZHEIMER, COVID-19, DEMÊNCIA, INFECÇÕES POR CORONAVIRUS, CORONAVIRUS, COGNIÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DAMIANO, Rodolfo Furlan et al. Cognitive decline following acute viral infections: literature review and projections for post-COVID-19. European Archives of Psychiatry and Clinical Neuroscience, p. 1-16, 2021Tradução . . Disponível em: https://doi.org/10.1007/s00406-021-01286-4. Acesso em: 20 maio 2024.
APA
Damiano, R. F., Guedes, B. F., Rocca, C. C. de, Serafim, A. de P., Castro, L. H. M., Munhoz, C. D., et al. (2021). Cognitive decline following acute viral infections: literature review and projections for post-COVID-19. European Archives of Psychiatry and Clinical Neuroscience, 1-16. doi:10.1007/s00406-021-01286-4
NLM
Damiano RF, Guedes BF, Rocca CC de, Serafim A de P, Castro LHM, Munhoz CD, Nitrini R, Busatto Filho G, Miguel Filho EC, Lucchetti G, Forlenza OV. Cognitive decline following acute viral infections: literature review and projections for post-COVID-19 [Internet]. European Archives of Psychiatry and Clinical Neuroscience. 2021 ; 1-16.[citado 2024 maio 20 ] Available from: https://doi.org/10.1007/s00406-021-01286-4
Vancouver
Damiano RF, Guedes BF, Rocca CC de, Serafim A de P, Castro LHM, Munhoz CD, Nitrini R, Busatto Filho G, Miguel Filho EC, Lucchetti G, Forlenza OV. Cognitive decline following acute viral infections: literature review and projections for post-COVID-19 [Internet]. European Archives of Psychiatry and Clinical Neuroscience. 2021 ; 1-16.[citado 2024 maio 20 ] Available from: https://doi.org/10.1007/s00406-021-01286-4
Artigo de periodico
Is cannabidiol the ideal drug to treat non-motor Parkinson’s disease symptoms? (2019)
Crippa, José Alexandre de Souza ; Hallak, Jaime Eduardo Cecilio ; Zuardi, Antônio Waldo ; Guimarães, Francisco Silveira ; Tumas, Vitor ; Santos, Rafael Guimarães dos
Source: European Archives of Psychiatry and Clinical Neuroscience. Unidade: FMRP
Subjects: DOENÇA DE PARKINSON, CANABINOIDES, SINTOMAS E PATOLOGIA GERAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CRIPPA, José Alexandre de Souza et al. Is cannabidiol the ideal drug to treat non-motor Parkinson’s disease symptoms?. European Archives of Psychiatry and Clinical Neuroscience, v. 269, n. 1, p. 121-133, 2019Tradução . . Disponível em: https://doi.org/10.1007/s00406-019-00982-6. Acesso em: 20 maio 2024.
APA
Crippa, J. A. de S., Hallak, J. E. C., Zuardi, A. W., Guimarães, F. S., Tumas, V., & Santos, R. G. dos. (2019). Is cannabidiol the ideal drug to treat non-motor Parkinson’s disease symptoms? European Archives of Psychiatry and Clinical Neuroscience, 269( 1), 121-133. doi:10.1007/s00406-019-00982-6
NLM
Crippa JA de S, Hallak JEC, Zuardi AW, Guimarães FS, Tumas V, Santos RG dos. Is cannabidiol the ideal drug to treat non-motor Parkinson’s disease symptoms? [Internet]. European Archives of Psychiatry and Clinical Neuroscience. 2019 ; 269( 1): 121-133.[citado 2024 maio 20 ] Available from: https://doi.org/10.1007/s00406-019-00982-6
Vancouver
Crippa JA de S, Hallak JEC, Zuardi AW, Guimarães FS, Tumas V, Santos RG dos. Is cannabidiol the ideal drug to treat non-motor Parkinson’s disease symptoms? [Internet]. European Archives of Psychiatry and Clinical Neuroscience. 2019 ; 269( 1): 121-133.[citado 2024 maio 20 ] Available from: https://doi.org/10.1007/s00406-019-00982-6
Artigo de periodico
Increased iPLA2 activity and levels of phosphorylated GSK3B in platelets are associated with donepezil treatment in Alzheimer’s disease patients (2015)
Talib, L. L.; Hototian, S. R.; Joaquim, H. P. G.; Forlenza, O. V.; Gattaz, W. F.
Source: European Archives of Psychiatry and Clinical Neuroscience. Unidade: FM
Subjects: DOENÇA DE ALZHEIMER, FÁRMACOS (SISTEMA NERVOSO CENTRAL), PROTEÍNAS QUINASES, FOSFOLIPASES A
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TALIB, L. L. et al. Increased iPLA2 activity and levels of phosphorylated GSK3B in platelets are associated with donepezil treatment in Alzheimer’s disease patients. European Archives of Psychiatry and Clinical Neuroscience, v. 265, n. 8, p. 701-706, 2015Tradução . . Disponível em: http://link.springer.com/article/10.1007/s00406-015-0600-6. Acesso em: 20 maio 2024.
APA
Talib, L. L., Hototian, S. R., Joaquim, H. P. G., Forlenza, O. V., & Gattaz, W. F. (2015). Increased iPLA2 activity and levels of phosphorylated GSK3B in platelets are associated with donepezil treatment in Alzheimer’s disease patients. European Archives of Psychiatry and Clinical Neuroscience, 265( 8), 701-706. doi:10.1007/s00406-015-0600-6
NLM
Talib LL, Hototian SR, Joaquim HPG, Forlenza OV, Gattaz WF. Increased iPLA2 activity and levels of phosphorylated GSK3B in platelets are associated with donepezil treatment in Alzheimer’s disease patients [Internet]. European Archives of Psychiatry and Clinical Neuroscience. 2015 ; 265( 8): 701-706.[citado 2024 maio 20 ] Available from: http://link.springer.com/article/10.1007/s00406-015-0600-6
Vancouver
Talib LL, Hototian SR, Joaquim HPG, Forlenza OV, Gattaz WF. Increased iPLA2 activity and levels of phosphorylated GSK3B in platelets are associated with donepezil treatment in Alzheimer’s disease patients [Internet]. European Archives of Psychiatry and Clinical Neuroscience. 2015 ; 265( 8): 701-706.[citado 2024 maio 20 ] Available from: http://link.springer.com/article/10.1007/s00406-015-0600-6
Artigo de periodico
Lower phosphorylated glycogen synthase kinase 3B levels in platelets of patients with schizophrenia: Increment by olanzapine treatment (2015)
Ferreira, Aline Siqueira; Raposo, Nadia R. Barbosa; Sallet, Paulo Clemente; van de Bilt, Martinius T.; Vieira, Rodrigo Machado; Gattaz, Wagner Farid; Talib, Leda Leme
Source: European Archives of Psychiatry and Clinical Neuroscience. Unidade: FM
Subjects: ESQUIZOFRENIA (COMPLICAÇÕES), PLAQUETAS SANGUÍNEAS, ENZIMAS (DEFICIÊNCIA), FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, Aline Siqueira et al. Lower phosphorylated glycogen synthase kinase 3B levels in platelets of patients with schizophrenia: Increment by olanzapine treatment. European Archives of Psychiatry and Clinical Neuroscience, v. 265, n. 2, p. 167-170, 2015Tradução . . Disponível em: https://doi.org/10.1007/s00406-014-0505-9. Acesso em: 20 maio 2024.
APA
Ferreira, A. S., Raposo, N. R. B., Sallet, P. C., van de Bilt, M. T., Vieira, R. M., Gattaz, W. F., & Talib, L. L. (2015). Lower phosphorylated glycogen synthase kinase 3B levels in platelets of patients with schizophrenia: Increment by olanzapine treatment. European Archives of Psychiatry and Clinical Neuroscience, 265( 2), 167-170. doi:10.1007/s00406-014-0505-9
NLM
Ferreira AS, Raposo NRB, Sallet PC, van de Bilt MT, Vieira RM, Gattaz WF, Talib LL. Lower phosphorylated glycogen synthase kinase 3B levels in platelets of patients with schizophrenia: Increment by olanzapine treatment [Internet]. European Archives of Psychiatry and Clinical Neuroscience. 2015 ; 265( 2): 167-170.[citado 2024 maio 20 ] Available from: https://doi.org/10.1007/s00406-014-0505-9
Vancouver
Ferreira AS, Raposo NRB, Sallet PC, van de Bilt MT, Vieira RM, Gattaz WF, Talib LL. Lower phosphorylated glycogen synthase kinase 3B levels in platelets of patients with schizophrenia: Increment by olanzapine treatment [Internet]. European Archives of Psychiatry and Clinical Neuroscience. 2015 ; 265( 2): 167-170.[citado 2024 maio 20 ] Available from: https://doi.org/10.1007/s00406-014-0505-9
Artigo de periodico-carta/editorial
Comment on Tükel et al., ‘‘The clinical impact of mood disorder comorbidity on obsessive-compulsive disorder’’ [Carta] (2007)
Diniz, Juliana Belo; Issler, Cilly Klüuger; Lafer, Beny; Miguel, Eurípedes Constantino
Source: European Archives of Psychiatry and Clinical Neuroscience. Unidade: FM
Subjects: TRANSTORNO DO HUMOR, TRANSTORNO OBSESSIVO-COMPULSIVO, COMORBIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DINIZ, Juliana Belo et al. Comment on Tükel et al., ‘‘The clinical impact of mood disorder comorbidity on obsessive-compulsive disorder’’ [Carta]. European Archives of Psychiatry and Clinical Neuroscience. Darmstadt: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://www.springerlink.com/content/l7775565r8587735/fulltext.pdf. Acesso em: 20 maio 2024. , 2007
APA
Diniz, J. B., Issler, C. K., Lafer, B., & Miguel, E. C. (2007). Comment on Tükel et al., ‘‘The clinical impact of mood disorder comorbidity on obsessive-compulsive disorder’’ [Carta]. European Archives of Psychiatry and Clinical Neuroscience. Darmstadt: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://www.springerlink.com/content/l7775565r8587735/fulltext.pdf
NLM
Diniz JB, Issler CK, Lafer B, Miguel EC. Comment on Tükel et al., ‘‘The clinical impact of mood disorder comorbidity on obsessive-compulsive disorder’’ [Carta] [Internet]. European Archives of Psychiatry and Clinical Neuroscience. 2007 ; 257 183-184.[citado 2024 maio 20 ] Available from: http://www.springerlink.com/content/l7775565r8587735/fulltext.pdf
Vancouver
Diniz JB, Issler CK, Lafer B, Miguel EC. Comment on Tükel et al., ‘‘The clinical impact of mood disorder comorbidity on obsessive-compulsive disorder’’ [Carta] [Internet]. European Archives of Psychiatry and Clinical Neuroscience. 2007 ; 257 183-184.[citado 2024 maio 20 ] Available from: http://www.springerlink.com/content/l7775565r8587735/fulltext.pdf
Artigo de periodico
Insight and regional brain volumes in schizophrenia (2007)
Bassitt, Débora Pastore; Louzã Neto, Mario Rodrigues; Castro, Cláudio Campi de; Busatto Filho, Geraldo
Source: European Archives of Psychiatry and Clinical Neuroscience. Unidade: FM
Subjects: ESQUIZOFRENIA, INSIGHT, IMAGEM POR RESSONÂNCIA MAGNÉTICA, CÉREBRO (RADIOGRAFIA)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BASSITT, Débora Pastore et al. Insight and regional brain volumes in schizophrenia. European Archives of Psychiatry and Clinical Neuroscience, v. 257, p. 58-62, 2007Tradução . . Disponível em: https://doi.org/10.1007/s00406-006-0685-z. Acesso em: 20 maio 2024.
APA
Bassitt, D. P., Louzã Neto, M. R., Castro, C. C. de, & Busatto Filho, G. (2007). Insight and regional brain volumes in schizophrenia. European Archives of Psychiatry and Clinical Neuroscience, 257, 58-62. doi:10.1007/s00406-006-0685-z
NLM
Bassitt DP, Louzã Neto MR, Castro CC de, Busatto Filho G. Insight and regional brain volumes in schizophrenia [Internet]. European Archives of Psychiatry and Clinical Neuroscience. 2007 ; 257 58-62.[citado 2024 maio 20 ] Available from: https://doi.org/10.1007/s00406-006-0685-z
Vancouver
Bassitt DP, Louzã Neto MR, Castro CC de, Busatto Filho G. Insight and regional brain volumes in schizophrenia [Internet]. European Archives of Psychiatry and Clinical Neuroscience. 2007 ; 257 58-62.[citado 2024 maio 20 ] Available from: https://doi.org/10.1007/s00406-006-0685-z
Artigo de periodico
Association between BanI genotype and increased phospholipase A2 activity in schizophrenia (2007)
Barbosa, Nadia R.; Junqueira, Ricardo M.; Vallada Filho, Homero P.; Gattaz, Wagner Farid
Source: European Archives of Psychiatry and Clinical Neuroscience. Unidade: FM
Subjects: GENÓTIPOS, FOSFOLIPASES A, POLIMORFISMO, ESQUIZOFRENIA (ATIVIDADE)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BARBOSA, Nadia R. et al. Association between BanI genotype and increased phospholipase A2 activity in schizophrenia. European Archives of Psychiatry and Clinical Neuroscience, v. 257, p. 340-343, 2007Tradução . . Disponível em: https://doi.org/10.1007/s00406-007-0736-0. Acesso em: 20 maio 2024.
APA
Barbosa, N. R., Junqueira, R. M., Vallada Filho, H. P., & Gattaz, W. F. (2007). Association between BanI genotype and increased phospholipase A2 activity in schizophrenia. European Archives of Psychiatry and Clinical Neuroscience, 257, 340-343. doi:10.1007/s00406-007-0736-0
NLM
Barbosa NR, Junqueira RM, Vallada Filho HP, Gattaz WF. Association between BanI genotype and increased phospholipase A2 activity in schizophrenia [Internet]. European Archives of Psychiatry and Clinical Neuroscience. 2007 ; 257 340-343.[citado 2024 maio 20 ] Available from: https://doi.org/10.1007/s00406-007-0736-0
Vancouver
Barbosa NR, Junqueira RM, Vallada Filho HP, Gattaz WF. Association between BanI genotype and increased phospholipase A2 activity in schizophrenia [Internet]. European Archives of Psychiatry and Clinical Neuroscience. 2007 ; 257 340-343.[citado 2024 maio 20 ] Available from: https://doi.org/10.1007/s00406-007-0736-0
Artigo de periodico
Lower P300 amplitude in eight-year-old offspring of alcoholic fathers with a delinquent history (2007)
Viana-Wackermann, Paula C.; Furtado, Erikson Felipe; Esser, Günter; Schmidt, Martin H.; Laucht, Manfred
Source: European Archives of Psychiatry and Clinical Neuroscience. Unidade: FMRP
Subjects: ALCOOLISMO, PATERNIDADE, DELINQUÊNCIA, CRIANÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VIANA-WACKERMANN, Paula C. et al. Lower P300 amplitude in eight-year-old offspring of alcoholic fathers with a delinquent history. European Archives of Psychiatry and Clinical Neuroscience, v. 257, n. 4, p. 211-216, 2007Tradução . . Disponível em: https://doi.org/10.1007/s00406-006-0709-8. Acesso em: 20 maio 2024.
APA
Viana-Wackermann, P. C., Furtado, E. F., Esser, G., Schmidt, M. H., & Laucht, M. (2007). Lower P300 amplitude in eight-year-old offspring of alcoholic fathers with a delinquent history. European Archives of Psychiatry and Clinical Neuroscience, 257( 4), 211-216. doi:10.1007/s00406-006-0709-8
NLM
Viana-Wackermann PC, Furtado EF, Esser G, Schmidt MH, Laucht M. Lower P300 amplitude in eight-year-old offspring of alcoholic fathers with a delinquent history [Internet]. European Archives of Psychiatry and Clinical Neuroscience. 2007 ; 257( 4): 211-216.[citado 2024 maio 20 ] Available from: https://doi.org/10.1007/s00406-006-0709-8
Vancouver
Viana-Wackermann PC, Furtado EF, Esser G, Schmidt MH, Laucht M. Lower P300 amplitude in eight-year-old offspring of alcoholic fathers with a delinquent history [Internet]. European Archives of Psychiatry and Clinical Neuroscience. 2007 ; 257( 4): 211-216.[citado 2024 maio 20 ] Available from: https://doi.org/10.1007/s00406-006-0709-8
Artigo de periodico
Taenia solium DNA is present in the cerebrospinal fluid of neurocysticercosis patients and can be used for diagnosis (2006)
Almeida, Carolina R.; Ojopi, Elida P.; Nunes, Cáris M.; Machado, Luis R.; Takayanagui, Osvaldo M.; Livramento, José A.; Abraham, Ronaldo; Gattaz, Wagner F.; Vaz, Adelaide J.; Dias-Neto, Emmanuel
Source: European Archives of Psychiatry and Clinical Neuroscience. Unidades: FM, FCF, FMRP
Subjects: CESTODA, DNA, LÍQUIDO CEFALORRAQUIDIANO, MANIFESTAÇÕES NEUROLÓGICAS, CISTICERCOSE (DIAGNÓSTICO)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALMEIDA, Carolina R. et al. Taenia solium DNA is present in the cerebrospinal fluid of neurocysticercosis patients and can be used for diagnosis. European Archives of Psychiatry and Clinical Neuroscience, v. 256, n. 4, p. 307-310, 2006Tradução . . Disponível em: https://doi.org/10.1007/s00406-006-0612-3. Acesso em: 20 maio 2024.
APA
Almeida, C. R., Ojopi, E. P., Nunes, C. M., Machado, L. R., Takayanagui, O. M., Livramento, J. A., et al. (2006). Taenia solium DNA is present in the cerebrospinal fluid of neurocysticercosis patients and can be used for diagnosis. European Archives of Psychiatry and Clinical Neuroscience, 256( 4), 307-310. doi:10.1007/s00406-006-0612-3
NLM
Almeida CR, Ojopi EP, Nunes CM, Machado LR, Takayanagui OM, Livramento JA, Abraham R, Gattaz WF, Vaz AJ, Dias-Neto E. Taenia solium DNA is present in the cerebrospinal fluid of neurocysticercosis patients and can be used for diagnosis [Internet]. European Archives of Psychiatry and Clinical Neuroscience. 2006 ; 256( 4): 307-310.[citado 2024 maio 20 ] Available from: https://doi.org/10.1007/s00406-006-0612-3
Vancouver
Almeida CR, Ojopi EP, Nunes CM, Machado LR, Takayanagui OM, Livramento JA, Abraham R, Gattaz WF, Vaz AJ, Dias-Neto E. Taenia solium DNA is present in the cerebrospinal fluid of neurocysticercosis patients and can be used for diagnosis [Internet]. European Archives of Psychiatry and Clinical Neuroscience. 2006 ; 256( 4): 307-310.[citado 2024 maio 20 ] Available from: https://doi.org/10.1007/s00406-006-0612-3
Artigo de periodico
Childhood meningitis, brain maturation and the risk of psychosis (2004)
Gattaz, Wagner Farid; Abrahão, André L.; Foccacia, Roberto
Source: European Archives of Psychiatry and Clinical Neuroscience. Unidade: FM
Subjects: MENINGITE, TRANSTORNOS PSICÓTICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GATTAZ, Wagner Farid e ABRAHÃO, André L. e FOCCACIA, Roberto. Childhood meningitis, brain maturation and the risk of psychosis. European Archives of Psychiatry and Clinical Neuroscience, v. 254, p. 23-26, 2004Tradução . . Disponível em: https://doi.org/10.1007/s00406-004-0431-3. Acesso em: 20 maio 2024.
APA
Gattaz, W. F., Abrahão, A. L., & Foccacia, R. (2004). Childhood meningitis, brain maturation and the risk of psychosis. European Archives of Psychiatry and Clinical Neuroscience, 254, 23-26. doi:10.1007/s00406-004-0431-3
NLM
Gattaz WF, Abrahão AL, Foccacia R. Childhood meningitis, brain maturation and the risk of psychosis [Internet]. European Archives of Psychiatry and Clinical Neuroscience. 2004 ; 254 23-26.[citado 2024 maio 20 ] Available from: https://doi.org/10.1007/s00406-004-0431-3
Vancouver
Gattaz WF, Abrahão AL, Foccacia R. Childhood meningitis, brain maturation and the risk of psychosis [Internet]. European Archives of Psychiatry and Clinical Neuroscience. 2004 ; 254 23-26.[citado 2024 maio 20 ] Available from: https://doi.org/10.1007/s00406-004-0431-3
Artigo de periodico
Association of a new polymorphism in ALOX12 gene with bipolar disorder (2003)
Fridman, Cintia; Ojopi, Élida P. B.; Gregório, Sheila P.; Ikenaga, Elisa H.; Moreno, Doris H.; Demetrio, Frederico N.; Guimarães, Pedro E. M.; Vallada, Homero P.; Gattaz, Wagner Farid; Dias Neto, Emmanuel
Source: European Archives of Psychiatry and Clinical Neuroscience. Unidade: FM
Subjects: TRANSTORNO BIPOLAR, POLIMORFISMO, LÍTIO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FRIDMAN, Cintia et al. Association of a new polymorphism in ALOX12 gene with bipolar disorder. European Archives of Psychiatry and Clinical Neuroscience, v. 253, p. 40-43, 2003Tradução . . Disponível em: https://doi.org/10.1007/s00406-003-0404-y. Acesso em: 20 maio 2024.
APA
Fridman, C., Ojopi, É. P. B., Gregório, S. P., Ikenaga, E. H., Moreno, D. H., Demetrio, F. N., et al. (2003). Association of a new polymorphism in ALOX12 gene with bipolar disorder. European Archives of Psychiatry and Clinical Neuroscience, 253, 40-43. doi:10.1007/s00406-003-0404-y
NLM
Fridman C, Ojopi ÉPB, Gregório SP, Ikenaga EH, Moreno DH, Demetrio FN, Guimarães PEM, Vallada HP, Gattaz WF, Dias Neto E. Association of a new polymorphism in ALOX12 gene with bipolar disorder [Internet]. European Archives of Psychiatry and Clinical Neuroscience. 2003 ; 253 40-43.[citado 2024 maio 20 ] Available from: https://doi.org/10.1007/s00406-003-0404-y
Vancouver
Fridman C, Ojopi ÉPB, Gregório SP, Ikenaga EH, Moreno DH, Demetrio FN, Guimarães PEM, Vallada HP, Gattaz WF, Dias Neto E. Association of a new polymorphism in ALOX12 gene with bipolar disorder [Internet]. European Archives of Psychiatry and Clinical Neuroscience. 2003 ; 253 40-43.[citado 2024 maio 20 ] Available from: https://doi.org/10.1007/s00406-003-0404-y

USP Schools

ReP

Filtros

Departament

Authors

USP affiliated authors

Date published

Subjects

Funding Agencies

Indexado em

Non normalized affiliation

Countries of institutions of collaboration